<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04416659</url>
  </required_header>
  <id_info>
    <org_study_id>3002</org_study_id>
    <nct_id>NCT04416659</nct_id>
  </id_info>
  <brief_title>Flow Arrest Safety and Technical Success With Balloon Guide Catheters</brief_title>
  <acronym>FAST-BGC</acronym>
  <official_title>Flow Arrest Safety and Technical Success With Balloon Guide Catheters</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Marblehead Medical</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Marblehead Medical</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The objective of this post-market registry is to assess technical efficacy and safety
      associated with the use of the Marblehead Balloon Guide Catheter during neuro-vascular
      procedures while providing temporary arrest of blood flow.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This is a prospective, multi-center, non-randomized observational registry evaluating use of
      Marblehead balloon guide catheters in patients diagnosed with an acute ischemic stroke due to
      large intracranial vessel occlusion.
    </textblock>
  </detailed_description>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">July 2020</start_date>
  <completion_date type="Anticipated">December 2020</completion_date>
  <primary_completion_date type="Anticipated">December 2020</primary_completion_date>
  <study_type>Observational [Patient Registry]</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <target_duration>1 Week</target_duration>
  <primary_outcome>
    <measure>Safety Evaluation</measure>
    <time_frame>Hospital discharge or 7 days</time_frame>
    <description>Incidence of device-related adverse events</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Performance Evaluation</measure>
    <time_frame>Completion of procedure</time_frame>
    <description>Successful use of the BGC during procedure</description>
  </primary_outcome>
  <enrollment type="Anticipated">100</enrollment>
  <condition>Acute Ischemic Stroke</condition>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Neuro-vascular access</intervention_name>
    <description>Adjunctive device providing a conduit for retrieval device during thrombectomy</description>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Patients with acute ischemic stroke
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Acute ischemic stroke vessel occlusion (ICA, M1 or M2) of the anterior circulation
             with associated symptoms

          -  Adult patient willing to provide Informed Consent

          -  Pre-treatment National Institutes of Health Stroke Scale (NIHSS) â‰¥ 6

        Exclusion Criteria:

          -  Posterior circulation stroke

          -  Tandem occlusions

          -  Cervical carotid stenosis

          -  Participating in another clinical trial
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Biraj Patel, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Carilion Clinic</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Claire Houston, MS</last_name>
    <phone>6502453467</phone>
    <email>cshclinical@gmail.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Kevin Kallmes</last_name>
    <phone>5072717051</phone>
    <email>kevinkallmes@supedit.com</email>
  </overall_contact_backup>
  <verification_date>June 2020</verification_date>
  <study_first_submitted>May 21, 2020</study_first_submitted>
  <study_first_submitted_qc>June 3, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">June 4, 2020</study_first_posted>
  <last_update_submitted>June 3, 2020</last_update_submitted>
  <last_update_submitted_qc>June 3, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">June 4, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
    <ipd_description>It is not yet known if there will be a plan to make IPD available.</ipd_description>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

